Diebold Nixdorf, Incorporated
DBD
$79.50
-$1.74-2.14%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.46% | -2.86% | -3.75% | -2.66% | -0.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46% | -2.86% | -3.75% | -2.66% | -0.25% |
| Cost of Revenue | -0.04% | -3.93% | -5.86% | -4.98% | -2.81% |
| Gross Profit | 5.88% | 0.43% | 3.04% | 4.91% | 8.17% |
| SG&A Expenses | 0.26% | 7.15% | 5.87% | -3.28% | -7.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -70.00% | -192.31% | 200.00% | -206.25% | -138.46% |
| Total Operating Expenses | -0.16% | -2.26% | -3.88% | -4.73% | -3.76% |
| Operating Income | 21.72% | -10.00% | -1.91% | 35.34% | 84.20% |
| Income Before Tax | 143.98% | 19.73% | -98.77% | -96.25% | -96.57% |
| Income Tax Expenses | -62.52% | -69.11% | -64.91% | 26.60% | -15.06% |
| Earnings from Continuing Operations | 771.72% | 2,565.00% | -100.47% | -100.54% | -101.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -40.00% | -50.00% | -75.00% | -46.67% | -300.00% |
| Net Income | 673.33% | 25,200.00% | -100.60% | -100.69% | -101.20% |
| EBIT | 21.72% | -10.00% | -1.91% | 35.34% | 84.20% |
| EBITDA | 11.70% | -7.75% | -3.56% | 19.24% | 46.56% |
| EPS Basic | 696.81% | 25,496.30% | -100.89% | -100.92% | -101.55% |
| Normalized Basic EPS | 48.01% | -14.66% | -0.49% | 285.40% | 927.47% |
| EPS Diluted | 682.40% | 124,100.00% | -100.91% | -100.95% | -101.59% |
| Normalized Diluted EPS | 46.36% | -15.28% | -0.65% | 284.19% | 929.94% |
| Average Basic Shares Outstanding | -2.19% | -1.00% | -11.64% | -29.11% | -40.75% |
| Average Diluted Shares Outstanding | -1.40% | -0.53% | -11.85% | -29.27% | -40.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |